KILITCH DRUGS (INDIA) LTD.
BSE: 524500
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 71.97+61.1% | 44.67+18.1% | 37.81+10.8% | 34.12-39.4% | 56.30+21.1% | 46.51+2.6% | 45.35 |
| Other Income | 1.14-29.3% | 1.61-78.9% | 7.61+117.7% | 3.50+50.4% | 2.32-1.9% | 2.37-59.2% | 5.81 |
| Total Income | 73.11+58.0% | 46.28+1.9% | 45.42+20.7% | 37.62-35.8% | 58.63+19.9% | 48.88-4.4% | 51.16 |
| EXPENSES | |||||||
| Expenditure | 53.78+34.1% | 40.11+13.5% | 35.35+11.7% | 31.64-27.5% | 43.63+10.8% | 39.36-3.0% | 40.58 |
| Tax | 5.33+316.1% | 1.28-5.7% | 1.36+14.4% | 1.19-67.2% | 3.62+37.5% | 2.64+51.9% | 1.74 |
| PROFIT | |||||||
| PBT | 19.33+213.2% | 6.17-38.7% | 10.07+68.4% | 5.98-60.1% | 15.00+57.6% | 9.52-10.0% | 10.58 |
| Net Profit | 14.00+186.2% | 4.89-43.9% | 8.72+81.8% | 4.79-57.9% | 11.37+65.2% | 6.88-22.2% | 8.85 |
| KEY METRICS | |||||||
| OPM % | 27.05%+14.24pp | 12.81%+3.10pp | 9.71%-0.76pp | 10.47%-14.23pp | 24.70%+11.41pp | 13.29%+4.58pp | 8.71% |
| NPM % | 19.15%+8.58pp | 10.57%-8.62pp | 19.19%+6.45pp | 12.74%-6.66pp | 19.40%+5.32pp | 14.08%-3.21pp | 17.29% |
| EPS | 4.08+48.9% | 2.74-48.0% | 5.27+76.8% | 2.98-57.9% | 7.07+65.2% | 4.28-22.2% | 5.50 |
Corporate Events
Board MeetingKILITCH
202628Jul
Board Meeting
The Board of Directors considered and approved the Notice of…
BSE Filing ↗ Board MeetingKILITCH
202613Mar
Board Meeting
The EGM will consider increasing the authorized share capita…
BSE Filing ↗ Board MeetingKILITCH
202412Nov
Board Meeting
Consider and approve unaudited Financial Results (Standalone…
BSE Filing ↗ Board MeetingKILITCH
20248Feb
Board Meeting
Consider and approve the unaudited standalone and consolidat…
BSE Filing ↗ Board MeetingKILITCH
20239Nov
Board Meeting
Consider and approve the unaudited Financial Results (Standa…
BSE Filing ↗ Board MeetingKILITCH
202311Aug
Board Meeting
consider and approve the unaudited Financial Results (Standa…
BSE Filing ↗